Purpose. Enteroviruses (EV) 71 and coxsackievirus A (CVA) 16 are the most prevalent EV serotypes responsible for hand, foot and mouth disease (HFMD). Nevertheless, CVA6 was found to be the leading cause of HFMD in the Nanjing area, of China in 2013. This study aims to provide insights into the occurrence of the emergent recombinant CVA6 through examination of the evolutionary history and the involved recombination events.
INTRODUCTION
Hand, foot and mouth disease (HFMD) is an infectious disease most commonly contracted by children, especially those under 5 years of age [1] . The typical syndromes of this disease are characterized by fever, vesicular rash over the hands, feet and buttocks, and oral ulceration [2, 3] . Although most HFMD cases are mild, severe complications presenting as neurological diseases such as encephalitis and meningitis may occur [4, 5] . In China, HFMD was incorporated into the National Notifiable Disease Surveillance System (NNDSS) in 2008, and laboratory surveillance was conducted to determine the causes of HFMD and its pathogen distribution. Diverse EV serotypes and subtypes have been identified as the causative agents responsible for HFMD, and the pathogen panel included EV71, CVA1-10, CVA12, CVA16, CVA22, CVB2-5 and echoviruses. In Nanjing City, the capital of Jiangsu Province, EV71 and CVA16 were reported as the two leading causes of HFMD in 2009, 2010 and 2011, accounting for the majority of HFMD infections. However, from 2013 to the present, the number of HFMD cases caused by CVA6 has increased dramatically. CVA6 became the most frequent pathogen in 2013, with a positive rate of 50.7 % among laboratoryconfirmed cases.
Effective molecular characterization is important for infectious disease surveillance and public health policy-making. Because CVA6 has been an emerging causative agent in the HFMD pathogen spectrum in Nanjing area since 2013, we were prompted to conduct this study to gain further insights into the genetic profiles of those CVA6 strains that constitute an unusually high proportion of infections. Regarding the emerging CVA6 strains observed in HFMD surveillance, Feng et al. [6] reported a novel recombinant CVA6 lineage associated with HFMD in Shanghai, China, in 2012-2013. In our study, a proportion of Nanjing CVA6 variants were assigned to the Shanghai recombinant strains in exactly the same clusters in the VP1, 2C and 3D regions. We also analysed the similarity of Nanjing and Shanghai recombinant CVA6 strains based on the full genome and found 98.70-99.42 % similarity between them. We believe that these CVA6 recombinant strains reported in the two studies belong to one single group and have the same molecular profile. As the recent appearance of RF-H of CVA6 associated with eczema herpeticum was reported in Edinburgh, UK [7] , we intended to determine the specific RF group to which these Nanjing and Shanghai recombinant CVA6 strains belong. We also analysed the recombination events involved in the generation of the RF group using the Simplot program. In addition, we explored the timescale that might account for the evolutionary history of the RFs, using molecular clock phylogeny.
METHODS

Surveillance of HFMD in Nanjing
The epidemiology of sporadic HFMD cases of viral origin was monitored in 22 sentinel hospitals through the HFMD Surveillance System. According to the Guideline for HFMD Diagnosis and Treatment (2010) released by the National Health and Family Planning Commission, clinically diagnosed HFMD cases are defined as those having rashes on the mouth, hands, feet and/or buttocks, accompanied by fever in the epidemic season, most commonly occurring in pre-school-aged children. Some cases may not be accompanied by fever. A minority of severe cases may not have typical skin lesions. Confirmation require positive laboratory identification of the pathogen. A total of 1307 throat swabs were taken from 16 551 HFMD suspected patients in the period from January to December 2013. All samples were taken from outpatients during their consultation and from inpatients within 72 h of admission. The samples were transferred in 3 ml viral transport medium (YOCON, Beijing, China) and stored at À70 C if RNA extraction was not to be conducted immediately. All samples were tested for pan-enterovirus, EV71 and CVA16. For those samples positive for enterovirus but negative for EV71 and CVA16, the presence of CVA6 was tested for. A subset of approximately 38.4 % (104/271) of CVA6-positive samples was sequenced based on the 915 bp VP1, 425 bp non-structural 2C and 812 bp non-structural 3Dpol sequences. All aspects of the study were carried out in accordance with national ethics regulations and were approved by the Science and Technology Committee of Nanjing CDC. Since the data from this study were obtained from routine disease surveillance and were de-identified, the requirement for written consent from the patients was waived.
Nucleic acid extraction and real-time reverse transcription (RT-PCR) Viral RNA extraction was performed using a QIAamp viral RNA minikit (Qiagen, Hilden, Germany). RNA from each sample was amplified using a commercial real-time PCR detection kit targeting enterovirus, EV71 and CVA16 (BioPerfectus Technologies, Taizhou, China) and the ABI 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). CVA6 was detected using a commercial real-time PCR Kit targeting CVA6 and CVA10 (BioPerfectus Technologies, Taizhou, China).
Sequencing and analysis PCR primers VP1-CA6F/VP1-CA6R for the amplification of the entire VP1 gene of CVA6 were designed using software Primer Premier version 5.0. PCR primers 2C-CA6F/ 2C-CA6R and 3D-CA6F/3D-CA6R for the amplification of non-structural 2C and 3Dpol genes, respectively, are described previously [6] . A Primer-Script one step RT-PCR kit Ver.2 (Takara, Japan) was used to conduct RT-PCR as previously described [8] . Briefly, one-step RT-PCR was performed in a 25 µl reaction mixture following the manufacturer's protocol. The cycling profile was as follows: 42 C for 15 min, 95 C for 1 min, followed by 40 cycles at 95 C for 20 s, 50 C for 30 s, 72 C for 50 s and a final step at 72 C for 10 min. Additionally, eight CVA6 strains in our study were sequenced for the full-length genome using eight pairs of primers, among which five primer sets (1113CA6F/ 2059CA6R, 1762CA6F/2717CA6R, 2C-CA6F/2C-CA6R, 4441CA6F/5760CA6R and 5642CA6F/6921CA6R) were reported [6] , and the remainder (5¢UTR-CA6F/5¢UTR-CA6R, VP1-CA6F/VP1-CA6R and 3¢UTR-CA6F/3¢UTR-CA6R) were designed using Primer Premier version 5.0 (Table. S1, available in the online version of this article). All PCR products were separated by electrophoresis on 1.5 % agarose gel. RT-PCR products targeting specific regions were sequenced in GenScript Corporation (Nanjing, China) using the ABI3730 instrument (Applied Biosystems, Foster City, CA). The sequences were edited and assembled by Molecular Evolutionary Genetics Analysis (MEGA) software version 5.2 [9] . The 915 bp VP1, 425 bp 2C and 812 bp 3D regions of CVA6 strains were aligned with a set of cognate reference sequences retrieved from the GenBank database. The dendrograms were generated using MEGA software version 5.2 by the neighbour-joining (NJ) method. Bootstrap was calculated with 1000 pseudo-replicated datasets. Pairwise nucleotide similarities between CVA6 and other EVA strains were performed. Recombination analysis used Simplot program version 3.2 [10] on the basis of complete genomes.
Evolution of the extant CVA6 strains was analysed by Bayesian Evolutionary Analysis Sampling Trees (BEAST) v 1.6.22 [11] and the Bayesian Markov chain Monte Carlo (MCMC) method to evaluate lineage divergence and tMRCA. The GTR substitution model with estimated base frequencies and a site heterogeneity model of gamma + invariant sites were used for VP1 and 3Dpol, with a strict clock under a previous constant population size tree.
RESULTS
Epidemiological features
In year 2011, 1647 specimens from clinically diagnosed sporadic HFMD cases were collected according to the requirements of the surveillance system. There were 46. Phylogenic analysis of CVA6 strains based on VP1, 2C and 3D regions In total, for the complete VP1 (915 bp), partial 2C (425 bp) and partial 3D (812 bp), 104, 76 and 32 sequences were obtained, respectively. We selected 28 CVA6 strains from which all three target sequences were available for further study. All sequences were registered in the GenBank database under accession numbers MF962663-MF962690 (VP1), MF962691-MF962718 (partial 2C) and MF962719- 
MF962746 (partial 3D
). The almost complete sequences of eight CVA6 variants from the year 2013 were deposited in GenBank under accession numbersMF991290 to MF991297.
As Gaunt et al. [7] have reported eight recombinant forms (RFs) of CVA6 over the past 10 years, we analysed the phylogeny of local CVA6 variants aiming to determine the recombinant groups to which those variants belong. Unexpectedly, we found a proportion of CVA6 strains clustered distinct from all other RFs in the phylogenetic tree based on the partial 3Dpol region and forming a single novel recombination group, namely RF-J (Fig. 1c) , since RF-I has been designated to the prototype Gdula. Meanwhile the other Nanjing CVA6 fell into the RF-A group which contained strains probably associated with atypical HFMD (aHFMD) from 2008 onwards worldwide, including variants from Taiwan (2010-2011), Edinburgh (2012 Edinburgh ( -2013 and Finland (2008) (Fig. 1c) . We found that the so-called non-recombinant CVA6 in Shanghai [6] was grouped into RF-A in the 3Dpol topology. Other parts of the CVA6 genome other than 3D were also analysed, including the VP1 and 2C regions (Fig. 1a, b) . In the VP1 region (Fig. 1a) , roughly four clades were formed. Clade 1 contained all the strains of RF-E, F, H, J and some strains of RF-A, including all 14 Nanjing study strains assigned to RF-J and 13 of the 14 Nanjing study strains of RF-A. Clade 2 included all the strains of RF-G, and some strains of RF-A, including a single Nanjing strain (APK1334-NJ-CHN-2013) which clustered more closely with a Japanese strain (AB678778, 2011). Clade 3 comprised RF-B, C, D and one relatively early Japanese RF-A strain (AB779616, 2003). Clade 4 comprised the prototype Gdula and an early strain detected in Shangdong Province, China in 1992. Despite the close relationship with those Nanjing RF-A strains, especially AGC1310/NJ/CHN/ 2013 and AJY1303/NJ/CHN/2013, the separate grouping of Nanjing RF-J strains was apparent in the VP1 region. We noted that RF-A was different from other recombination groups in that those strains were scattered over the phylogeny tree of VP1, appearing in all three main clades.
The RF-A group apparently presented a more divergent VP1, which may reflect its relatively long development history compared to other RF groups. In regard to the 2C region, distinct grouping of each RF group was also seen with the exception of RF-E, which clustered within the branch formed by RF-A.
In this study, the incongruency found in structural and NS gene topology is indicative of the existence of recombination. Comparing RF-J and RF-A, the position of the variants in the VP1, 2C and 3D phylogenetic trees suggested that the breaking point may occur in the 2A or 2B region, which is between VP1 and 2C. Some RF groups presented different characteristics. For example, the breaking point for RF-E may lie in the 3A/3B/3C region, which is between 2C and 3D.
We then conducted an identity analysis based on the fulllength genome to gain further information. The identities of a representative RF-J strain (ALS1319/NJ/CHN) with the strains of other RF groups and some EVA strains are presented in Table 1 . Generally, among these CVA6 RF groups, ALS1319/NJ/CHN exhibited a high identity of 96.70-97.96 %, 93.24-96.61 % and 94.67-95.33 % with strains RF-A, RF-F and RF-H in the 5¢-UTR, P1 (VP4-VP1) and 2A regions, respectively. It was also noted that ALS1319/NJ/ CHN showed highest identity (97.00 %) with the RF-E strain in the VP1 region, although identity with RF-E was below 90 % in the VP4 and 2A regions. Comparison of strains RF-J and RF-A~RF H showed that identity decreased to 81.71-88.89 % in the 2B-2C region and to 80.23-87.38 % in the P3 (3A-3D) region, respectively, suggesting that a Table 1 . Pair-wise nucleotide sequence similarities between Nanjing RF-J sequences and other CVA6 RF groups and certain EVA strains of high similarity
The representative strains were ABX1323/NJ/CHN of RF-A, AB779614 of RF-B, AB779617 of RF-C, JQ964234 of RF-D, JQ946050 of RF-E, KP144341 of RF-F, KP144551 of RF-G, KP144347 of RF-H, EV71-GD (JF799986, Guangdong), CVA4-SZ (HQ728260, Shenzhen), CVA2-SD (HQ728259, Shandong) and CVA8-SZ (KM609479, Shenzhen). [6] reported that the Shanghai recombinant CVA6 strains shared an identity of 91.0-92.4 % with a recombinant EV71 strain (Guangdong, JF799986) [12] and a CVA4 strain (Shenzhen, HQ728260) [13] in the 2C region, suggesting possible recombination events with these EVA serotypes. In this study, we obtained similar results in our analysis of the 2C region, while also identifying closely related sequences among a CVA8 strain (Shenzhen, KM609479) [14] in the identity analysis of the P3 region.
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Defining recombination breakpoint
Occurrences of recombination were evident, which consequently requires the mapping of recombination breakpoints. The full-length genome of six RF-J CVA6 and two RF-A strains was detected, and Simplot software was used to confirm the recombination events and to identify the position of breakpoints (Fig. 2) . The query sequence RF-J strain ALS1319/NJ/CHN was closely related to the RF-A strain ABX1323/NJ/CHN in the first part of the sequence, which corresponded to the regions from 5'UTR to 2A (1~3780 bp). However, similarity then dropped below 90 %, which is in accordance with the rather low percentage of identity beyond the 2A region reported in Table 1 (88.89 % in 2B and 82.78 % in 2C). Recombination events were confirmed with a breakpoint at position 4001~4045, corresponding to the 2B region of the CVA6 genome. We noted that the sequence of the RF-J strain between nucleotides 4149 and 4840 bp (corresponding to region 2C) was close to EV71 (JF799986) and CVA4 (HQ728260), suggesting the insertion of a 691 bp sequence of known source. The NS region beyond position 4866~4873 (corresponding to the P3 region and that adjacent to P3 in 2C) is considered a more conserved region of the EVA strains, and therefore it is not surprising that the sequences of this region between different serotypes including RF-A CVA6 (ABX1323/NJ/CHN), the recombinant EV71 (JF799986), CVA4 (HQ728260) and CVA2 (HQ728259) were shared. However, in this region, the query RF-J strain showed closer association with a CVA8 strain (Shenzhen, KM609479) rather than the others. It appeared that the second recombination event may have occurred with a CVA8 strain which is considered the putative source of recombinant sequences. It has been reported that the 2C gene of the Shanghai recombinant strains possibly derived from a co-circulating CVA4 strain [6] ; we nevertheless further suggested the occurrence of a second recombination event involving CVA8 in the generation of RF-J.
Timescale of specific recombination events
In terms of the VP1 gene (Fig. 3a) , the time of origin of the Nanjing RF-J CVA6 was estimated to be the year 2011 and the 95 % highest posterior density (HPD) interval was 2010~2012. The Nanjing RF-J CVA6 strains were most closely related to the two RF-A strains AGC1310/NJ/CHN/ 2013 and AJY1303/NJ/CHN/2013, and evolved from a common ancestor around the year 2010. RF-E, RF-F, RF-G and RF-H were also most closely related to RF-A strains and diverged from variable RF-A strains; the year of divergence is shown in Table 2 . The detailed temporal history of RF-B, RF-C and RF-D is not available, but these RF groups do not appear to be related to the main clade of RF-A. In addition, the appearance of RF-B was the earliest as shown in the temporal phylogeny. In terms of the 3Dpol gene (Fig. 3b) , the Nanjing RF-J CVA6 strains fell within a distinct cluster that was different from the Nanjing RF-A CVA6, and was most closely related to CVA8. The RF-J CVA6 diverged from the CVA8 cluster around the year 2000 (Table 2) 
DISCUSSION
Taking the timescales of 3D and VP1 together, we partially unveiled the evolutionary history of the CVA6 strains. First, in regard to VP1, we agree that RF-E, RF-F, RF-G and RF-H have a common ancestral form, RF-A, as reported [7] . We further showed that the VP1 of RF-J also diverged from that of RF-A strains. VP1 is the hypervariable capsid protein that plays an important role in confronting immune pressure and eliciting antibody reactions. This property is often used to provide classification results for EVA. All the VP1 sequences of RF-A, except the early one AB779616/JPN/ 2003, were distributed into a major partition, with tMRCA dating back to the year 1997 (95 % HPD interval: 1995~2001). In this partition, groups containing RF-E, RF-H, RF-J, RF-F and RF-G were originated and the time of divergence was as indicated in Fig. 3(a) and Table 2 . Among these groups, RF-J and RF-H appeared more recently and were prevalent in different geographical regions. RF-J was found in cities in Southeast China (Nanjing and Shanghai), and RF-H was reported only in Edinburgh, UK. Recombinant groups were more reliably inferred from the 3D gene rather than from VP1, as can be observed from Fig. 1 . It was speculated that various CVA6 RFs may have corresponding clinical presentations, which indeed suggested the role of 3D in disease association. While aHFMD (worldwide after 2008) and herpangina are related to RF-A and RF-E, respectively, aHFMD cases presenting as eczema herpeticum from Edinburgh in 2014 formed a novel cluster, RF-H. It was assumed that CVA6 variants from 2011 which were not associated with HFMD may be related to RF-D and RF-C [7] . Considering the possible differences between recombination groups with regard to their clinical phenotypes, we tried to observe the clinical manifestations that may be associated with the RF-J group. The patients included in our study were those with rashes compatible with the diagnostic criteria mentioned above. Although lacking sufficient clinical samples to conduct statistical analyses in this study, we noted that all the RF-J CVA6 strains from Nanjing and the two Shanghai recombinant CVA6 strains (KJ541161 and KJ541162) clustered in the same group in regions 3Dpol, 2C and VP1 ( Fig. 1) and had a genetic similarity of 98.70-99.42 % in the whole genome. It was reported that Shanghai recombinant CVA6 strains involved widespread skin lesions, especially on the upper and lower limbs and anterior trunk, compared to nonrecombinant strains (i.e. RF-A strain). Therefore we speculated that the novel RF group J, which contained emerging recombinant CVA6 variants from Nanjing and Shanghai in 2013, may be associated with aHFMD characteristic of wider skin eruption compared to local RF-A strains.
We conclude that: (1) There are several limitations to this study. First, the sample size of CVA6 variants was very limited. Although we included all available sequences published in GenBank that could match the regions we studied, most studies focused on VP1 sequences among which the whole-genome sequence or the paired NS regions are not accessible. The estimated time-scale and reconstruction of lineage divergence are therefore not accurate, especially for strains extant before 2008. Second, the clinical outcomes recorded in some sentinel hospitals are not detailed, which makes problematic the linkage of genetic profiles to clinical phenotypes. We can only infer the clinical association based on the report from Shanghai. In addition, although CVA6 can cause herpangina as well as HFMD, the former is not included in NNDSS in China. Therefore, whether there are differences between the genetic features of local CVA6 strains responsible for herpangina and those which cause HFMD remains to be further elucidated.
